| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |